Recent studies have outlined the ability of ROS to engage with CAFs in a two-way cross-talk, where CAFs increase the levels of ROS observed in the tumor tissue, promoting cancer growth and invasiveness, while ROS activate the CAFs through the upregulation of HIF1α [24]. Here, HIF1A is linked to cancer.